Charité leads on three new EU-funded projects

More than €10 million in funding awarded to Charité

More

Berlin partners and the University of Oxford consolidate their cooperation

The research partnership between the University of Oxford and the four Berlin partners – Freie Universität Berlin, Humboldt-Universität zu Berlin, Technische Universität Berlin, and Charité – Universitätsmedizin Berlin – is picking up speed: all five...

More

NOXXON announces key findings that NOX-A12 plus Keytruda® induces an immune response and results in clinical benefit for patients

Findings include stable disease and prolonged time on treatment vs. prior therapy in heavily pretreated metastatic pancreatic and colorectal cancer patients

More

How dietary fiber and gut bacteria protect the cardiovascular system

The fatty acid propionate helps defend against the effects of high blood pressure, including atherosclerosis and heart tissue remodeling, a study on mice has found. Gut bacteria produce the substance – which calms the immune cells that drive up blood...

More

Prostate cancer – New computer model enables researchers to predict course of disease

How does a normal cell turn into a deadly cancer? Seeking an answer to this question, and working alongside other international working groups, researchers from Charité – Universitätsmedizin Berlin examined the tumor genomes of nearly 300 prostate...

More

ERC Synergy Grant awarded to project exploring playful learning

Implementing a project entitled ‘BrainPlay’, an interdisciplinary team of researchers will explore the way in which play affects the human brain. Researchers from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH),...

More

Are we immune to the CRISPR-Cas9 gene editing scissors?

The CRISPR-Cas9 gene editing system has been generating excitement within the field of gene therapy, inspiring hopes of molecular tools capable of treating genetic diseases. By studying immune responses to CRISPR-Cas9 in humans, researchers from...

More

Clariness today announced it has acquired Viomedo, a leading online platform for clinical trials and provider of patient enrollment services


Over the last 13 years, Clariness has built a patient recruitment business covering 45 countries and 8 of
the top 10 pharmaceutical companies. “Clinical trials face increasing challenges in terms of cost and
timelines. Clariness strives to drive...

More

Layer-by-Layer nanoscale coatings, surface modification, micro encapsulation and bead based microsensors (pH, temperature, oxygen, chloride, bioanalysis) for co-development of innovative applications

The German SME focuses on three technologies in the field of nanotechnology and biotechnology: tailored surface modification and encapsulation mainly by the Layer-by-Layer (LbL) technology platform; bead-based microsensors for bioanalysis; and...

More

Rapid and Specific Detection of most common Fungal Nail and Skin Infections

Reference Number TO 32-00053

More
Show more items